154 related articles for article (PubMed ID: 25348735)
1. siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines.
Song Y; Mu L; Han X; Liu X; Fu S
Acta Biochim Biophys Sin (Shanghai); 2014 Dec; 46(12):1034-40. PubMed ID: 25348735
[TBL] [Abstract][Full Text] [Related]
2. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
3. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Sato A; Okada M; Shibuya K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Kayama T; Kitanaka C
Stem Cell Res; 2013 Jul; 11(1):601-10. PubMed ID: 23651583
[TBL] [Abstract][Full Text] [Related]
5. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y
Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928
[TBL] [Abstract][Full Text] [Related]
6. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
7. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
Gong X; Schwartz PH; Linskey ME; Bota DA
Neurology; 2011 Mar; 76(13):1126-34. PubMed ID: 21346220
[TBL] [Abstract][Full Text] [Related]
8. Stathmin expression in glioma-derived microvascular endothelial cells: a novel therapeutic target.
Dong B; Mu L; Qin X; Qiao W; Liu X; Yang L; Xue L; Rainov NG; Liu X
Oncol Rep; 2012 Mar; 27(3):714-8. PubMed ID: 22038457
[TBL] [Abstract][Full Text] [Related]
9. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
10. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma.
Wang Y; Huang N; Li H; Liu S; Chen X; Yu S; Wu N; Bian XW; Shen HY; Li C; Xiao L
Oncotarget; 2017 Jun; 8(23):37511-37524. PubMed ID: 28415586
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
[TBL] [Abstract][Full Text] [Related]
12. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
[TBL] [Abstract][Full Text] [Related]
13. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
14. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.
Li Y; Li L; Wu Z; Wang L; Wu Y; Li D; Ma U; Shao J; Yu H; Wang D
Oncol Rep; 2017 Jul; 38(1):325-335. PubMed ID: 28560406
[TBL] [Abstract][Full Text] [Related]
15. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
[TBL] [Abstract][Full Text] [Related]
16. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
17. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells.
Hu X; Wu N; Xia P; Yu S; Sun F; Chen J
Cancer Chemother Pharmacol; 2012 May; 69(5):1205-12. PubMed ID: 22258403
[TBL] [Abstract][Full Text] [Related]
18. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
[TBL] [Abstract][Full Text] [Related]
19. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
[TBL] [Abstract][Full Text] [Related]
20. Pituitary tumor transforming gene: a novel therapeutic target for glioma treatment.
Cui L; Xu S; Song Z; Zhao G; Liu X; Song Y
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):414-21. PubMed ID: 25908389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
